Vericel (VCEL) Preferred Shares (2013 - 2016)
Vericel (VCEL) posted Preferred Shares of $38.4 million for Q4 2016, little changed sequentially from $38.4 million in Q3 2016, and little changed YoY from $38.4 million in Q1 2016.
Vericel (VCEL) Preferred Shares (2013 - 2016) Analysis & Trends
Vericel has reported Preferred Shares for 4 years, with the latest figure at $38.4 million in Q4 2016.
- Quarterly Preferred Shares changed 0.0% year-over-year to $38.4 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $38.4 million (changed 0.0% YoY) and the FY2016 annual result came in at $38.4 million, changed 0.0% from the prior year.
- Preferred Shares held at $38.4 million in Q4 2016 per VCEL's latest filing, from $38.4 million in the prior quarter.
- Over five years, Preferred Shares peaked at $38.4 million in Q3 2013 and troughed at $38.4 million in Q3 2013.
- A 4-year average of $38.4 million and a median of $38.4 million in 2013 frame the typical range for Preferred Shares.
- The widest YoY moves for Preferred Shares: up 0.0% in 2014, down 0.0% in 2014.
- Over 4 years, Preferred Shares stood at $38.4 million in 2013, then changed by 0.0% to $38.4 million in 2014, then changed by 0.0% to $38.4 million in 2015, then changed by 0.0% to $38.4 million in 2016.
- According to Business Quant data, Preferred Shares over the past three periods registered $38.4 million, $38.4 million, and $38.4 million for Q4 2016, Q3 2016, and Q2 2016 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Vericel | 2.26 Bn | 2.10 Bn | 56.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 38.39 Mn |
| Sep 30, 2016 | 38.39 Mn |
| Jun 30, 2016 | 38.39 Mn |
| Mar 31, 2016 | 38.39 Mn |
| Dec 31, 2015 | 3.15 Mn |
| Sep 30, 2015 | 38.39 Mn |
| Jun 30, 2015 | 38.39 Mn |
| Mar 31, 2015 | 38.39 Mn |
| Sep 30, 2014 | 38.39 Mn |
| Jun 30, 2014 | 38.39 Mn |
| Mar 31, 2014 | 38.39 Mn |
| Dec 31, 2013 | 38.39 Mn |
| Sep 30, 2013 | 38.39 Mn |